A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
Eli Lilly and Company
Pheast Therapeutics
NiKang Therapeutics, Inc.
Regor Pharmaceuticals Inc.
Seagen Inc.
Pliant Therapeutics, Inc.
BioNTech SE
Eli Lilly and Company
Eli Lilly and Company
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
MOMA Therapeutics
Kestrel Therapeutics, Inc.
Mersana Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Context Therapeutics Inc.
OncoC4, Inc.
Compass Therapeutics
Revolution Medicines, Inc.
USWM, LLC (dba US WorldMeds)
Fate Therapeutics
Epsilogen Ltd
Boehringer Ingelheim
IDEAYA Biosciences
Agenus Inc.
Radiopharm Theranostics, Ltd
Cogent Biosciences, Inc.
Whitehawk Therapeutics, Inc.
GlaxoSmithKline
SystImmune Inc.
Institut Paoli-Calmettes
Xencor, Inc.
Atavistik Bio, Inc
Whitehawk Therapeutics, Inc.
NiKang Therapeutics, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
AstraZeneca
Alterome Therapeutics, Inc.
Sutro Biopharma, Inc.
University of Miami
Accent Therapeutics
AbbVie
Myeloid Therapeutics
Tizona Therapeutics, Inc